Endurant Capital Management LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,775,000
-23.4%
71,640
+19.9%
0.62%
+2.1%
Q1 2022$2,316,000
+6.0%
59,732
+60.0%
0.61%
+15.7%
Q4 2021$2,184,000
-50.7%
37,325
-26.9%
0.53%
-56.7%
Q2 2021$4,429,000
+300.1%
51,031
+279.9%
1.22%
+321.1%
Q1 2021$1,107,000
-81.7%
13,432
-79.8%
0.29%
-86.8%
Q4 2020$6,055,000
+169.5%
66,585
+18.5%
2.18%
+228.9%
Q3 2020$2,247,000
+7.6%
56,210
-7.7%
0.66%
+477.4%
Q2 2020$2,089,000
+130.8%
60,892
+49.5%
0.12%
-72.0%
Q1 2020$905,000
-65.7%
40,732
-69.8%
0.41%
-50.7%
Q4 2019$2,642,000
+2.0%
135,022
-19.0%
0.83%
-10.5%
Q3 2019$2,590,000
-22.2%
166,782
-18.4%
0.93%
-37.2%
Q3 2018$3,329,000
+255.7%
204,333
+147.5%
1.48%
+264.8%
Q2 2018$936,000
-38.3%
82,572
-46.8%
0.41%
-28.3%
Q1 2018$1,516,000
-55.4%
155,344
-72.1%
0.57%
-45.6%
Q4 2017$3,401,000
+214.9%
556,679
+104.1%
1.04%
+218.0%
Q3 2017$1,080,000272,7000.33%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders